Fluvoxamine Studies | Video

Steve Kirsch, founder of the COVID-19 Early Treatment Fund (CETF) discussed the evidence backing fluvoxamine as a treatment for COVID-19.

Responses

  1. Research has suggested that fluvoxamine and fluoxetine had similar effects for depression. Would they have similar benefits for COVID? Thank you.

  2. Convincing enough for me…

    Why do Covid patients need government endorsement except that they are trained to first ask their doctor, then the doctor knows little to none about what they are asking, then the doctor does the distancing thing and Voila!, the patient’s mind is turned against research (unless the 3 letter agencies announce how promising their recommendation can be.

    I don’t know how to educate doctors. I tried to tell a cardiologist about Ivermectin but he wouldn’t listen if it didn’t have FDA approval for the disease. He didn’t even know what ivermectin was.

    1. Ivey, two of my doctors are the same way. I don’t think they make the effort to stay current, relying on the FDA and the media to tell them what to believe. They’re sheep, just like most other people. I talked about Covid-19 treatments with one of my docs, ran down the list of 10 or more treatments … every single one she said doesn’t work. Talked about vitamins and supplements with another of them; the best response I got was “that’s a good one” when I mentioned NAC, and a reference to an outside lab where I could get vitamin and mineral levels checked. Medical practice has become a factory process on auto-pilot. Doctors are “too busy” to think or learn, just matching symptoms against a list and handing out the chemicals the Pharm reps are pushing this season.